Russ J Bioorg Chem 44:4151 Ciuffreda P, Xynomilakis O, Casati S, Ottria R (2024) Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes
Clinical evidence supports its use across the spectrum of disease severity, from newly diagnosed patients to those with longstanding diabetes inadequately controlled on multiple oral agents or basal insulin
The evidence is still developing, and this combination is approached as an individualized, provider-directed option with honest expectations never a stand-alone healing shot, and never a replacement for proper rehab, sleep, nutrition, and balanced hormones
Book a quick 15-minute call with our clinic director to get your questions answered, see if you're a good fit for this revolutionary medication, and to finally start losing weight.
These medications work best as long-term treatments
According to the retatrutide trial results, the share of people who quit due to side effects was similar to that in other GLP-1 trials (between 4% and 11%, depending on the dose)
